Valuation: Celltrion, Inc.

Capitalization 40,106B 27.23B 23.41B 21.93B 20.44B 37.75B 2,451B 41.06B 256B 99.03B 1,157B 102B 100B 4,232B P/E ratio 2025 *
51.5x
P/E ratio 2026 * 34x
Enterprise value 41.12B 27.92M 24M 22.48M 20.95M 38.7M 2.51B 42.1M 263M 102M 1.19B 105M 103M 4.34B EV / Sales 2025 *
9.93x
EV / Sales 2026 * 8.32x
Free-Float
70.87%
Yield 2025 *
0.4%
Yield 2026 * 0.43%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.38%
1 week-1.24%
Current month-1.24%
1 month+4.80%
3 months+8.46%
6 months+16.88%
Current year+1.67%
More quotes
1 week 181,000
Extreme 181000
189,350
1 month 171,100
Extreme 171100
203,500
Current year 144,615.38
Extreme 144615.3846
203,500
1 year 144,615.38
Extreme 144615.3846
203,500
3 years 119,963.37
Extreme 119963.37
220,695.97
5 years 119,963.37
Extreme 119963.37
341,497.26
10 years 54,514.52
Extreme 54514.5171
341,497.26
More quotes
Manager TitleAgeSince
Chief Executive Officer - 2015-03-19
Director of Finance/CFO 50 -
Compliance Officer 43 -
Director TitleAgeSince
Chairman 68 -
Director/Board Member 67 2008-07-16
Director/Board Member 67 2008-07-16
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.38%-1.24%+10.59%+19.98% 27.23B
-0.95%-1.24%+4.46%+9.05% 47.37B
+0.41%-1.81%+12.96%+6.57% 38.46B
-2.56%-5.20%+60.12%+71.11% 35.73B
+0.61%-7.48%+60.13%+166.73% 15.44B
+1.48%+2.42%+68.37%+227.47% 15.4B
+0.05%+0.47%-11.28%-9.23% 14.19B
+0.43%-1.63%+44.21% - 13.64B
-0.16%-1.27%+122.26%+109.54% 13.23B
-1.51%-3.24%+55.55%+72.03% 12.55B
Average -0.51%-2.03%+42.74%+74.81% 23.32B
Weighted average by Cap. -0.61%-2.15%+33.81%+54.94%
See all sector performances

Financials

2025 *2026 *
Net sales 4,140B 2.81B 2.42B 2.26B 2.11B 3.9B 253B 4.24B 26.47B 10.22B 119B 10.55B 10.32B 437B 4,933B 3.35B 2.88B 2.7B 2.51B 4.64B 301B 5.05B 31.55B 12.18B 142B 12.57B 12.3B 521B
Net income 817B 555M 477M 447M 416M 769M 49.91B 836M 5.22B 2.02B 23.57B 2.08B 2.04B 86.19B 1,229B 835M 717M 672M 626M 1.16B 75.1B 1.26B 7.86B 3.03B 35.47B 3.13B 3.07B 130B
Net Debt 1,013B 687M 591M 554M 516M 953M 61.87B 1.04B 6.48B 2.5B 29.22B 2.58B 2.53B 107B 921B 625M 538M 504M 469M 867M 56.28B 943M 5.89B 2.27B 26.58B 2.35B 2.3B 97.18B
More financial data * Estimated data
Logo Celltrion, Inc.
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.
Employees
2,680
More about the company
Date Price Change Volume
25-12-05 183,300.00 +0.38% 476,038
25-12-04 182,600.00 -0.38% 467,290
25-12-03 183,300.00 -0.49% 393,784
25-12-02 184,200.00 -0.86% 376,417
25-12-01 185,800.00 +0.11% 399,280

End-of-day quote Korea S.E., December 04, 2025

More quotes
Trader
Investor
Global
Quality
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
183,300.00KRW
Average target price
223,458.07KRW
Spread / Average Target
+21.91%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A068270 Stock